ATOS icon

Atossa Therapeutics
ATOS

Overview Fund Trends Analyst Outlook Journalist POV

14 hedge funds and large institutions have $649K invested in Atossa Therapeutics in 2019 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 5 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

more funds holding

Funds holding: →

more first-time investments, than exits

New positions opened: | Existing positions closed:

less ownership

Funds ownership: →

less capital invested

Capital invested by funds: $ → $

60% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 5

Holders
14
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$43K
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$131K
2
+$108K
3
+$26K
4
TRCT
Tower Research Capital (TRC)
New York
+$6K

Top Sellers

1
-$234K
2
-$128K
3
-$92K
4
FDCDDQ
Federation des caisses Desjardins du Quebec
Quebec, Canada
-$12.8K
5
Barclays
Barclays
United Kingdom
-$4.25K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$308K
2
$229K
3
$33.1K
4
$26K
5
$26K
6
$14K
7
$6K
8
$5K
9
$2K
10
–
11
–
12
–